Dov Nitzan
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dov Nitzan.
Bioorganic & Medicinal Chemistry Letters | 2010
Hanbiao Yang; Robert Than Hendricks; Nidhi Arora; Dov Nitzan; Calvin Yee; Matthew C. Lucas; Yanli Yang; Amy Fung; Sonal Rajyaguru; Seth F. Harris; Vincent Leveque; Julie Q. Hang; Sophie Le Pogam; Deborah Carol Reuter; Gisele Tavares
Conformational modeling has been successfully applied to the design of cyclic bioisosteres used to replace a conformationally rigid amide bond in a series of thiophene carboxylate inhibitors of HCV NS5B polymerase. Select compounds were equipotent with the original amide series. Single-point mutant binding studies, in combination with inhibition structure-activity relationships, suggest this new series interacts at the Thumb-II domain of NS5B. Inhibitor binding at the Thumb-II site was ultimately confirmed by solving a crystal structure of 8b complexed with NS5B.
Drug Metabolism and Disposition | 2004
William L. Fitch; Pamela W. Berry; Ya-Ping Tu; Ali Tabatabaei; Lee Edwin Lowrie; Francisco Javier Lopez-Tapia; Yanzhou Liu; Dov Nitzan; Mohammad R. Masjedizadeh; Aravamuthan Varadarajan
The metabolic fate of three aromatic carboxylic acid analogs under evaluation as prostaglandin I2-preferring receptor antagonists was studied. The initial analog with unsubstituted phenyl groups was subject to a complex set of aromatic oxidative biotransformations. By introduction of one or two fluorines, these pathways were inhibited. All three analogs were metabolized to a wide variety of carboxylic acid conjugates. Among these were several conjugates formed via secondary metabolism and oxidation of acyl glutathione intermediates. Two of the structure classes, represented by the S-methyl-N-cysteinylglycine conjugate and the N-cysteinylglycine disulfide conjugates, have been described only rarely in the literature. The related S-oxide of the S-methyl-N-cysteinylglycine conjugate and the N,S-bis-acyl derivative of cysteinylglycine are here described for the first time as conjugate metabolites of car boxylic drugs.
Journal of Medicinal Chemistry | 2015
Francisco Javier Lopez-Tapia; Keith Adrian Murray Walker; Christine Brotherton-Pleiss; Joanie Caroon; Dov Nitzan; Lee Edwin Lowrie; Shelley K. Gleason; Shu-Hai Zhao; Jacob Berger; Debra Cockayne; Deborah Phippard; Rebecca T. Suttmann; William L. Fitch; David L. Bourdet; Pankaj D. Rege; Xiaojun Huang; Scott Broadbent; Charles Alois Dvorak; Jiang Zhu; Paul J. Wagner; Fernando Padilla; Brad Loe; Alam Jahangir; André Alker
Identification of singleton P2X7 inhibitor 1 from HTS gave a pharmacophore that eventually turned into potential clinical candidates 17 and 19. During development, a number of issues were successfully addressed, such as metabolic stability, plasma stability, GSH adduct formation, and aniline mutagenicity. Thus, careful modification of the molecule, such as conversion of the 1,4-dihydropyridinone to the 1,2-dihydropyridinone system, proper substitution at C-5″, and in some cases addition of fluorine atoms to the aniline ring allowed for the identification of a novel class of potent P2X7 inhibitors suitable for evaluating the role of P2X7 in inflammatory, immune, neurologic, or musculoskeletal disorders.
Tetrahedron Letters | 1999
Francisco J. Lopez; Dov Nitzan
Benzylic azides are converted into N-methylanilines efficiently in the presence of a Bronsted or Lewis acid and Et3SiH. The combination of SnCl4Et3SiH and 4-n-butylbenzyl azide appears to form an aminodiazonium trichlorostannate(II), which undergoes the rearrangement to an iminium salt that is then reduced to N-methyl-4-n-butylaniline by Et3SiH.
Archive | 2002
Francisco Javier Lopez-Tapia; Dov Nitzan; Counde O'yang
Archive | 2004
Terrence Joseph Connolly; Paul Francis Keitz; Eun Kyung Lee; Jim Li; Francisco Javier Lopez-Tapia; Patrick Finbar Mcgarry; Chris Richard Melville; Dov Nitzan; Counde O'yang; Fernando Padilla; Klaus Kurt Weinhardt
Archive | 2002
Francisco Javier Lopez-Tapia; Dov Nitzan; Counde O'yang
Heterocycles | 2002
Francisco J. Lopez; Mary-Frances Jett; Joseph M. Muchowski; Dov Nitzan; Counde O'yang
Archive | 2004
Terrence Joseph Connolly; Paul Francis Keitz; Eun Kyung Lee; Jim Li; Francisco Javier Lopez-Tapia; Patrick Finbar Mcgarry; Chris Richard Melville; Dov Nitzan; Counde O'yang; Fernando Padilla; Klaus Kurt Weinhardt
Archive | 2009
Christine E. Brotherton-Pleiss; Joan M. Caroon; Francisco Javier Lopez-Tapia; Dov Nitzan; Keith Adrian Murray Walker